Spanios Email Format

Biotechnology ResearchTexas, United States0-1 Employees

Spanios operates in the biotechnology research space, focusing on patient-derived tumoroids to accelerate solid tumor drug development. Its platform maintains stable, biobanked tumor models with an intact tumor microenvironment, enabling reproducible preclinical studies and the investigation of patient-specific tumor-immune interactions. By providing researchers with tunable, human-relevant tumor models, Spanios supports biomarker discovery, drug selection and combination therapy assessment, and the derisking of clinical trials in the realm of cancer therapeutics.

Headquartered in Houston, Texas, Spanios targets pharmaceutical, biotechnology, and academic researchers seeking robust preclinical models for cancer research. The company has formed partnerships with several organizations to expand its validation and screening capabilities, reflecting its positioning within the niche of human-derived organoid and tumoroid platforms used to validate solid-tumor therapies.

Sign up for free to view info

Company overview Employee directory